Abstract
Introduction: Efforts to reduce opioid overdose deaths in the United States have been stymied by the lack of timely and standardized population-level data for local, state, and national levels. The U.S. has a strong national need for linking opioid and other drug overdose surveillance data to service utilization data for overdose prevention and treatment to inform resource allocation and response planning. Methods: We provide insight on the challenges of identifying, obtaining, and harmonizing administrative outcome data across four states using the collective experience from the HEALing Communities Study to test a community-engaged, data-driven, population-level intervention to reduce opioid overdose deaths. We also discuss the opportunities that arose from those challenges, as well as the relationships across state agencies that were strengthened. Results: Challenges experienced by the research sites on obtaining administrative outcome data included issues around who owned the data, what level of data access and use was allowed, and difficulties related to the timeliness of the data, ability to harmonize the data elements, and lack of demographic data available for stratification. Opportunities arose from these challenges whereby research sites developed new partnerships with state agencies (including a key governmental official in the state administration), provided an additional layer of quality control for these data, and facilitated democratizing data so local communities could access them. Conclusions: The overall lessons show the importance of adapting to external changes and maintaining strong partnerships to pursue shared goals. The HCS serves as an exemplar of how local and state jurisdictions can create comprehensive data systems for monitoring and responding to the opioid overdose epidemic.
| Original language | English |
|---|---|
| Article number | 209832 |
| Journal | Journal of substance use and addiction treatment |
| Volume | 181 |
| DOIs |
|
| State | Published - Feb 2026 |
Bibliographical note
Publisher Copyright:© 2025
Funding
This research was supported by the National Institutes of Health and the Substance Abuse and Mental Health Services Administration through the NIH HEAL (Helping to End Addiction Long-term®) Initiative under award numbers UM1DA049394, UM1DA049406, UM1DA049412, UM1DA049415, UM1DA049417 (ClinicalTrials.gov Identifier: NCT04111939). Dr. Villani was substantially involved in UM1DA049394, UM1DA049406, UM1DA049412, UM1DA049415, and UM1DA049417 consistent with her role as Scientific Officer. This study protocol (Pro00038088) was approved by Advarra Inc., the HEALing Communities Study single Institutional Review Board. We wish to acknowledge the participation of the HEALing Communities Study communities, community coalitions, Community Advisory Boards, and state government officials who partnered with us on this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the Substance Abuse and Mental Health Services Administration or the NIH HEAL Initiative®.This research was supported by the National Institutes of Health and the Substance Abuse and Mental Health Services Administration through the NIH HEAL (Helping to End Addiction Long-term®) Initiative under award numbers UM1DA049394, UM1DA049406, UM1DA049412, UM1DA049415, UM1DA049417 (ClinicalTrials.gov Identifier: NCT04111939). Dr. Villani was substantially involved in UM1DA049394, UM1DA049406, UM1DA049412, UM1DA049415, and UM1DA049417 consistent with her role as Scientific Officers. This study protocol (Pro00038088) was approved by Advarra Inc., the HEALing Communities Study single Institutional Review Board. This research was supported by the National Institutes of Health and the Substance Abuse and Mental Health Services Administration through the NIH HEAL (Helping to End Addiction Long-term®) Initiative under award numbers UM1DA049394 , UM1DA049406 , UM1DA049412 , UM1DA049415 , UM1DA049417 ( ClinicalTrials.gov Identifier: NCT04111939 ). Dr. Villani was substantially involved in UM1DA049394, UM1DA049406, UM1DA049412, UM1DA049415, and UM1DA049417 consistent with her role as Scientific Officer. This study protocol (Pro00038088) was approved by Advarra Inc., the HEALing Communities Study single Institutional Review Board. We wish to acknowledge the participation of the HEALing Communities Study communities, community coalitions, Community Advisory Boards, and state government officials who partnered with us on this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the Substance Abuse and Mental Health Services Administration or the NIH HEAL Initiative®.
| Funders | Funder number |
|---|---|
| Substance Abuse and Mental Health Services Administration | |
| National Institutes of Health (NIH) | UM1DA049412, Pro00038088, UM1DA049394, UM1DA049415, NCT04111939, UM1DA049406, UM1DA049417 |
Keywords
- Administrative data
- Drug overdose
- Drug surveillance
- HEALing Communities Study
- Opioid overdoses
ASJC Scopus subject areas
- Medicine (miscellaneous)
- Psychiatric Mental Health
- Psychiatry and Mental health